AI assistant
Sarepta Therapeutics, Inc. — Director's Dealing 2012
Nov 16, 2012
31721_dirs_2012-11-15_1153ec76-0a03-4966-b954-db31d15e47b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-11-14
Reporting Person: CHASE ANTHONY R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-14 | Common Stock | S | 9200 | $25.6515 | Disposed | 28044 | Direct |
| 2012-11-14 | Common Stock | S | 800 | $26.26 | Disposed | 27244 | Direct |
Footnotes
F1: This transaction was executed in multiple trades in prices ranging from $25.15 to $26.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F2: This transaction was executed in multiple trades in prices ranging from $26.18 to $26.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.